{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:51:37Z","timestamp":1774533097889,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T00:00:00Z","timestamp":1530921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12958-018-0383-5","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T16:41:55Z","timestamp":1530981715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["FMR1 expression in human granulosa cells increases with exon 1 CGG repeat length depending on ovarian reserve"],"prefix":"10.1186","volume":"16","author":[{"given":"Julia","family":"Rehnitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego D.","family":"Alcoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilma S.","family":"Brum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens E.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe","family":"Youness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Hinderhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Messmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Freis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Strowitzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Germeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,7]]},"reference":[{"key":"383_CR1","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.AOG.0000264065.37661.a0","volume":"109","author":"DH Barad","year":"2007","unstructured":"Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol. 2007;109:1404\u201310.","journal-title":"Obstet Gynecol"},{"key":"383_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","volume":"20","author":"AK Sullivan","year":"2005","unstructured":"Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20:402\u201312.","journal-title":"Hum Reprod"},{"key":"383_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/humrep\/der018","volume":"26","author":"J Schuettler","year":"2011","unstructured":"Schuettler J, Peng Z, Zimmer J, Sinn P, von Hagens C, Strowitzki T, Vogt PH. Variable expression of the fragile X mental retardation 1 (FMR1) gene in patients with premature ovarian failure syndrome is not dependent on number of (CGG)n triplets in exon 1. Hum Reprod. 2011;26:1241\u201351.","journal-title":"Hum Reprod"},{"key":"383_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","volume":"67","author":"YH Fu","year":"1991","unstructured":"Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG Jr, Warren ST, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047\u201358.","journal-title":"Cell"},{"key":"383_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng0893-335","volume":"4","author":"D Devys","year":"1993","unstructured":"Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993;4:335\u201340.","journal-title":"Nat Genet"},{"key":"383_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","volume":"10","author":"A Kenneson","year":"2001","unstructured":"Kenneson A, Zhang F, Hagedorn CH, Warren ST. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet. 2001;10:1449\u201354.","journal-title":"Hum Mol Genet"},{"key":"383_CR7","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1017\/S1355838202020642","volume":"8","author":"B Primerano","year":"2002","unstructured":"Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA. 2002;8:1482\u20138.","journal-title":"RNA"},{"key":"383_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/386296","volume":"74","author":"PJ Hagerman","year":"2004","unstructured":"Hagerman PJ, Hagerman RJ. The fragile-X premutation: a maturing perspective. Am J Hum Genet. 2004;74:805\u201316.","journal-title":"Am J Hum Genet"},{"key":"383_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/brain\/awh683","volume":"129","author":"CM Greco","year":"2006","unstructured":"Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, et al. Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS). Brain J Neurol. 2006;129:243\u201355.","journal-title":"Brain J Neurol"},{"key":"383_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/brain\/awf184","volume":"125","author":"CM Greco","year":"2002","unstructured":"Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ. Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers. Brain J Neurol. 2002;125:1760\u201371.","journal-title":"Brain J Neurol"},{"key":"383_CR11","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/hmg\/ddg331","volume":"12","author":"LS Chen","year":"2003","unstructured":"Chen LS, Tassone F, Sahota P, Hagerman PJ. The (CGG)n repeat element within the 5\u2032 untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum Mol Genet. 2003;12:3067\u201374.","journal-title":"Hum Mol Genet"},{"key":"383_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1472-6483(10)60173-3","volume":"19","author":"N Gleicher","year":"2009","unstructured":"Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod BioMed Online. 2009;19:385\u201390.","journal-title":"Reprod BioMed Online"},{"key":"383_CR13","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10815-015-0577-0","volume":"32","author":"SL Gustin","year":"2015","unstructured":"Gustin SL, Ding VY, Desai M, Leader B, Baker VL. Evidence of an age-related correlation of ovarian reserve and FMR1 repeat number among women with \"normal\" CGG repeat status. J Assist Reprod Genet. 2015;32:1669\u201376.","journal-title":"J Assist Reprod Genet"},{"key":"383_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.rbmo.2010.02.020","volume":"20","author":"N Gleicher","year":"2010","unstructured":"Gleicher N, Weghofer A, Barad DH. Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing. Reprod BioMed Online. 2010;20:768\u201375.","journal-title":"Reprod BioMed Online"},{"key":"383_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1177\/1933719112446074","volume":"19","author":"LM Pastore","year":"2012","unstructured":"Pastore LM, Young SL, Baker VM, Karns LB, Williams CD, Silverman LM. Elevated prevalence of 35\u201344 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012;19:1226\u201331.","journal-title":"Reprod Sci"},{"key":"383_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.fertnstert.2016.09.032","volume":"107","author":"LM Pastore","year":"2017","unstructured":"Pastore LM, Young SL, Manichaikul A, Baker VL, Wang XQ, Finkelstein JS. Distribution of the FMR1 gene in females by race-ethnicity: women with diminished ovarian reserve versus women with normal fertility (SWAN study). Fertil Steril. 2017;107:205\u2013211.e1.","journal-title":"Fertil Steril"},{"key":"383_CR17","doi-asserted-by":"publisher","first-page":"e18781","DOI":"10.1371\/journal.pone.0018781","volume":"6","author":"N Gleicher","year":"2011","unstructured":"Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity\/race. PLoS One. 2011;6:e18781.","journal-title":"PLoS One"},{"key":"383_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/humrep\/des392","volume":"28","author":"M Voorhuis","year":"2013","unstructured":"Voorhuis M, Onland-Moret NC, Fauser BC, Ploos van Amstel HK, van der Schouw YT, Broekmans FJ. The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod. 2013;28:496\u2013501.","journal-title":"Hum Reprod"},{"key":"383_CR19","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.fertnstert.2016.02.011","volume":"105","author":"N Banks","year":"2016","unstructured":"Banks N, Patounakis G, Devine K, DeCherney AH, Widra E, Levens ED, Whitcomb BW, Hill MJ. Is FMR1 CGG repeat length a predictor of in vitro fertilization stimulation response or outcome? Fertil Steril. 2016;105:1537\u201346. e1538","journal-title":"Fertil Steril"},{"key":"383_CR20","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10815-016-0732-2","volume":"33","author":"BS Maslow","year":"2016","unstructured":"Maslow BS, Davis S, Engmann L, Nulsen JC, Benadiva CA. Correlation of normal-range FMR1 repeat length or genotypes and reproductive parameters. J Assist Reprod Genet. 2016;33:1149\u201355.","journal-title":"J Assist Reprod Genet"},{"key":"383_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.rbmo.2016.02.009","volume":"32","author":"SJ Morin","year":"2016","unstructured":"Morin SJ, Tiegs AW, Franasiak JM, Juneau CR, Hong KH, Werner MD, Zhan Y, Landis J, Scott RT Jr. FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles. Reprod BioMed Online. 2016;32:496\u2013502.","journal-title":"Reprod BioMed Online"},{"key":"383_CR22","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/humrep\/dew204","volume":"31","author":"KS Ruth","year":"2016","unstructured":"Ruth KS, Bennett CE, Schoemaker MJ, Weedon MN, Swerdlow AJ, Murray A. Length of FMR1 repeat alleles within the normal range does not substantially affect the risk of early menopause. Hum Reprod. 2016;31:2396\u2013403.","journal-title":"Hum Reprod"},{"key":"383_CR23","doi-asserted-by":"publisher","first-page":"e105121","DOI":"10.1371\/journal.pone.0105121","volume":"9","author":"SE Elizur","year":"2014","unstructured":"Elizur SE, Lebovitz O, Derech-Haim S, Dratviman-Storobinsky O, Feldman B, Dor J, Orvieto R, Cohen Y. Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers. PLoS One. 2014;9:e105121.","journal-title":"PLoS One"},{"issue":"8","key":"383_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ajmg.b.32277","volume":"165B","author":"MR Mailick","year":"2014","unstructured":"Mailick MR, Hong J, Greenberg J, Smith L, Sherman S. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. Am J Med Genet B Neuropsychiatr Genet. 2014;165B(8):705\u201311.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"383_CR25","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, Definition Ewgo POR. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the bologna criteria. Hum Reprod. 2011;26:1616\u201324.","journal-title":"Hum Reprod"},{"key":"383_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","unstructured":"Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum Reprod"},{"key":"383_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2174\/092986706776872943","volume":"13","author":"W Fassnacht","year":"2006","unstructured":"Fassnacht W, Mempel A, Strowitzki T, Vogt PH. Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. Curr Med Chem. 2006;13:1397\u2013410.","journal-title":"Curr Med Chem"},{"key":"383_CR28","first-page":"173","volume":"277","author":"V Stoyanova","year":"2004","unstructured":"Stoyanova V, Oostra BA. The CGG repeat and the FMR1 gene. Methods Mol Biol. 2004;277:173\u201384.","journal-title":"Methods Mol Biol"},{"key":"383_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156\u20139.","journal-title":"Anal Biochem"},{"key":"383_CR30","first-page":"532","volume":"15","author":"P Chomczynski","year":"1993","unstructured":"Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques. 1993;15:532\u20134. 536-537","journal-title":"BioTechniques"},{"key":"383_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abio.1999.4085","volume":"270","author":"J Winer","year":"1999","unstructured":"Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41\u20139.","journal-title":"Anal Biochem"},{"key":"383_CR32","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ijc.2910530415","volume":"53","author":"CA van den Berg-Bakker","year":"1993","unstructured":"van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI. Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer. 1993;53:613\u201320.","journal-title":"Int J Cancer"},{"key":"383_CR33","doi-asserted-by":"publisher","first-page":"e15303","DOI":"10.1371\/journal.pone.0015303","volume":"5","author":"N Gleicher","year":"2010","unstructured":"Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS One. 2010;5:e15303.","journal-title":"PLoS One"},{"key":"383_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ejhg.2014.185","volume":"23","author":"V Biancalana","year":"2015","unstructured":"Biancalana V, Glaeser D, McQuaid S, Steinbach P. EMQN best practice guidelines for the molecular genetic testing and reporting of fragile X syndrome and other fragile X-associated disorders. Eur J Hum Genet. 2015;23:417\u201325.","journal-title":"Eur J Hum Genet"},{"key":"383_CR35","doi-asserted-by":"publisher","first-page":"e102274","DOI":"10.1371\/journal.pone.0102274","volume":"9","author":"VA Kushnir","year":"2014","unstructured":"Kushnir VA, Yu Y, Barad DH, Weghofer A, Himaya E, Lee HJ, Wu YG, Shohat-Tal A, Lazzaroni-Tealdi E, Gleicher N. Utilizing FMR1 gene mutations as predictors of treatment success in human in vitro fertilization. PLoS One. 2014;9:e102274.","journal-title":"PLoS One"},{"key":"383_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000441566","volume":"16","author":"MI Alvarez-Mora","year":"2016","unstructured":"Alvarez-Mora MI, Rodriguez-Revenga L, Feliu A, Badenas C, Madrigal I, Mil\u00e0 M. Skewed X inactivation in women carrying the FMR1 Premutation and its relation with fragile-X-associated tremor\/ataxia syndrome. Neurodegener Dis. 2016;16:290\u20132.","journal-title":"Neurodegener Dis"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0383-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-018-0383-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0383-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:47:17Z","timestamp":1720399637000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-018-0383-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1186\/s12958-018-0383-5","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,7]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved was approved by the local ethical committee of the University of Heidelberg, Germany (number S-602\/2013).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"65"}}